Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 4 (2007), Issue 10 (October)

1. Factors related to surgical complications and their impact on the functional status in 236 open surgeries for malignant tumors in a Latino-American hospital.
   Surg Neurol, 68(4): 412-20; discussion 420. [Abstract] [Full-text]
2. New candidate chromosomal regions for chordoma development.
   Surg Neurol, 68(4): 425-30; discussion 430. [Abstract] [Full-text]
3. Impact of age on complications and outcome in meningioma surgery.
   Surg Neurol, 68(4): 407-11; discussion 411. [Abstract] [Full-text]
4. Progress in magnetic resonance imaging of brain tumours.
   Curr Opin Oncol, 19(6): 616-22. [Abstract] [Full-text]
5. Recent development in chemotherapy of paediatric brain tumours.
   Curr Opin Oncol, 19(6): 612-5. [Abstract] [Full-text]
6. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
   Curr Opin Oncol, 19(6): 606-11. [Abstract] [Full-text]
7. Molecular targeted therapies and chemotherapy in malignant gliomas.
   Curr Opin Oncol, 19(6): 598-605. [Abstract] [Full-text]
8. Autocrine glutamate signaling promotes glioma cell invasion.
   Cancer Res, 67(19): 9463-71. [Abstract] [Full-text]
9. Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses.
   Cancer Res, 67(19): 9398-406. [Abstract] [Full-text]
10. In vivo significance of the G2 restriction point.
    Cancer Res, 67(19): 9244-7. [Abstract] [Full-text]
11. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
    Cancer Res, 67(19): 8994-9000. [Abstract] [Full-text]
12. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    J Neuropathol Exp Neurol, 66(10): 944-54. [Abstract] [Full-text]
13. Survival among children with medulloblastoma in Greece: gains from transition to chemotherapy and socio-economic differentials.
    Eur J Cancer Prev, 16(5): 460-5. [Abstract] [Full-text]
14. Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
    J Clin Oncol, 25(29): 4622-7. [Abstract] [Full-text]
15. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.
    Science, 318(5848): 287-90. [Abstract] [Full-text]
16. The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequences.
    J Neurosci, 27(42): 11214-27. [Abstract] [Full-text]
17. Risk for leukaemia and brain and breast cancer among Danish utility workers: a second follow-up.
    Occup Environ Med, 64(11): 782-4. [Abstract] [Full-text]
18. High-grade astrocytoma in very young children.
    Pediatr Blood Cancer, 49(7): 888-93. [Abstract] [Full-text]
19. Attention dysfunction and parent reporting in children with brain tumors.
    Pediatr Blood Cancer, 49(7): 970-4. [Abstract] [Full-text]
20. Intraoperative MRI with a rotating, tiltable surgical table: a time use study and clinical results in 122 patients.
    AJR Am J Roentgenol, 189(5): 1096-103. [Abstract] [Full-text]
21. Tumors of the central nervous system in the first year of life.
    Pediatr Blood Cancer, 49(7): 1074-82. [Abstract] [Full-text]
22. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
    Acta Radiol, 48(9): 1032-7. [Abstract] [Full-text]
23. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
    Cancer, 110(9): 2035-41. [Abstract] [Full-text]
24. Assessment of the astrogliotic responses of three human astrocytoma cell lines to ethanol, trimethyltin chloride and acrylamide.
    Toxicology, 241(1): 75-83. [Abstract] [Full-text]
25. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts.
    Int J Radiat Oncol Biol Phys, 69(4): 1254-61. [Abstract] [Full-text]
26. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
    Int J Radiat Oncol Biol Phys, 69(4): 1246-53. [Abstract] [Full-text]
27. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    J Clin Oncol, 25(31): 4987-92. [Abstract] [Full-text]
28. (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.
    Int J Cancer, 121(12): 2637-45. [Abstract] [Full-text]

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.